FL Treatment Tool
Challenging the Current Treatment Paradigm for Patients With Follicular Lymphoma: Recent and Emerging Evidence

Released: March 31, 2023

Expiration: December 14, 2024

About This Tool & Disclaimer

Interactive Decision Support Tool: Expert Treatment Guidance for Follicular Lymphoma

Clinical Care Options, LLC, is grateful to John M. Burke, MD; Christopher R. Flowers, MD, MS; Jean Koff, MD, MSc; Jeffrey Sharman, MD; and Pallawi Torka, MD who provided expert guidance, knowledge, and support in the development of this Interactive Decision Support Tool.

Note: The current tool was created in March 2023 and reflects the guidelines available at that time.

The goal of the tool is to educate healthcare professionals on making optimal management choices for monitoring or treating individuals with follicular lymphoma based on current NCCN, ESMO and other practice guidelines in the United States, and Europe.

A series of questions allow the user to select individual patient characteristics that are necessary to consider when making management choices. These characteristics include disease grade, tumor burden, presence of symptoms, fitness to withstand treatment, patient goals of treatment, and presence of EZH2 mutation. It should be noted that these are not exclusive characteristics when selecting optimal treatment for patients with follicular lymphoma. Other considerations that are not included in this tool, such as the presence of various comorbidities and any concurrent medications, should also be considered, when appropriate for making management decisions.

This tool assumes we have a “standard” patient with follicular lymphoma but with no additional features or specific comorbidities that would affect treatment choice other than those described when entering the patient details. Based on the characteristics entered, the tool will display guideline-based recommendations for that specific patient case.

For additional information on best practices in the management of patients with follicular lymphoma, please see our online module titled, “Current and Emerging Therapeutic Advances in Follicular Lymphoma: A Class in Session,” authored by John M. Burke, MD, and Jean Koff, MD, MS.

This program is supported by educational grants from Bristol-Myers Squibb, and Genentech, a member of the Roche Group.

© 2023 Clinical Care Options, LLC. All rights reserved.

Access to and use of this Interactive Decision Support Tool titled, “Interactive Decision Support Tool: Expert Treatment Guidance for Follicular Lymphoma” is provided subject to the following terms and conditions. PLEASE READ THESE TERMS CAREFULLY.

This Interactive Decision Support Tool is designed to educate healthcare professionals on making optimal management choices for monitoring or treating individuals with follicular lymphoma. The information provided is based on the NCCN, and ESMO guideline recommendations and expert guidance of John M. Burke, MD; Christopher R. Flowers, MD, MS; Jean Koff, MD, MSc; Jeffrey Sharman, MD; and Pallawi Torka, MD.

The material published by Clinical Care Options reflects the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the FDA. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Although the information contained in the “Interactive Decision Support Tool: Expert Treatment Guidance for Follicular Lymphoma” Interactive Decision Support Tool has been produced and processed from sources believed to be reliable, no warranty, expressed or implied, is made regarding the accuracy, adequacy, completeness, legality, reliability, or usefulness of any information. This disclaimer applies to both the isolated and aggregate uses of the information. Clinical Care Options provides this information on an as-is basis. This disclaimer applies to all material published by Clinical Care Options including but not limited to medical information or opinions. All warranties of any kind, expressed or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses, and noninfringement of proprietary rights are disclaimed.

Any trademarks are the property of respective companies.

© 2023 Clinical Care Options, LLC. All rights reserved.

Program Content